Genes2Me unveils CoviEasy self-test kit with 98% accuracy for COVID-19
Category: #business  | By Nikita Chaurasia  | Date: 2022-06-14 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Genes2Me unveils CoviEasy self-test kit with 98% accuracy for COVID-19

Genes2Me has recently announced the successful launch of a self-test rapid antigen test kit, CoviEasy for COVID-19, that provides faster results in 10 minutes.

Supported by AI-determined Mobile App, the IVD product offers concordance of nearly 98% accuracy and sensitivity.

CoviEasy has undergone several quality checks at the ICMR appropriate validation centre and received acceptance from CDSCO India.

As per credible sources, the CoviEasy test can be undertaken by following the simple instructions provided on the Mobile App (available on both iOS and Android platforms), resulting in automated reporting of test results from the mobile app itself.

The cost of the kit is said to be just $3.19.

The CoviEasy test includes a couple of steps as it is conducted with a nasal swab sampling, where the swab is injected into the nostrils. The swab must be immersed in the tube and swirled about eight to ten times in the extraction buffer. The buffer is then released onto the test equipment, showing the test results as negative or positive.

The test device is embedded with a QR code for patient data entry and report generation.

While commenting on the product launch, Neeraj Gupta, Genes2Me Founder and CEO, said that as now many people are opting to get the test done at home to detect whether they are positive or not, accuracy becomes the most critical and non-negotiable factor.

Neeraj added that the firm understood this need of the hour and devised a test kit which is more than 98 per cent accurate and effective.

The CoviEasy kit will be offering almost the results and effectiveness of RTPCR with the practicality of an at home self-test kit. The firm plans to aid society with the most accurate equipment in India and suffice the need with the advanced manufacturing unit.

Source Credit - https://www.expresshealthcare.in/news/genes2me-launches-covieasy-self-test-kit-for-covid-19/435370/

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Vietnam extends COVID-19 vaccine coverage to 12 years old and above

Vietnam extends COVID-19 vaccine coverage to 12 years old and above

By Nikita Chaurasia

Pham Minh Chính, Prime Minister of Vietnam, is prompting the Ministry of Health and local authorities to amplify the administration of third and fourth COVID-19 vaccine doses for individuals aged 12 years and above. If sources are to be bel...

Samsung kickstarts chip production with 3nm process technology

Samsung kickstarts chip production with 3nm process technology

By Nikita Chaurasia

Samsung Electronics Co Ltd has reportedly declared that it has begun the mass production of chips using advanced 3-nanometre technology. The company is the first in the entire world to do so and is actively looking for new clients to contest with Tai...

Progcap nabs $40Mn in funding round for expansion & product development

Progcap nabs $40Mn in funding round for expansion & product development

By Nikita Chaurasia

Progcap, a pioneer in the field of corporate-driven financing solutions for small and medium-sized businesses (SMBs), has secured $40 million in private equity capital at $600 million valuation. The raised capital forms a part of the Series C exte...